Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy-Reference-Cited by-同舟云学术

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy

Published:2016-06-16 Issue:28 Volume:7 Page:44608-44620
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Hyo Song¹,Shin Su-Jin²,Beom Seung-Hoon¹,Jung Minkyu¹,Choi Yoon Young³,Son Taeil³,Kim Hyoung-Il³,Cheong Jae-Ho³,Hyung Woo Jin³,Noh Sung Hoon³,Chung Hyunsoo⁴,Park Jun Chul⁴,Shin Sung Kwan⁴,Lee Sang Kil⁴,Lee Yong Chan⁴,Koom Woong Sub⁵,Lim Joon Seok⁶,Chung Hyun Cheol¹,Rha Sun Young¹,Kim Hyunki²

Affiliation:

1. Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

2. Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea

3. Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea

4. Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

5. Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea

6. Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastric cancer molecular classification based on immunohistochemistry and in‐situ hybridisation and mortality;Histopathology;2024-05-07

2. Assessment of programmed death-ligand 1 expression in primary tumors and paired lymph node metastases of gastric adenocarcinoma;World Journal of Gastrointestinal Oncology;2024-03-15

3. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study;Journal of Clinical Oncology;2024-01-20

4. Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy;Gastric Cancer;2023-11-25

5. Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapy;2023-10-28